LSE - Delayed Quote GBp

Creo Medical Group PLC (CREO.L)

Compare
18.50
-0.50
(-2.63%)
At close: January 17 at 3:33:16 PM GMT
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
30,800.00
30,800.00
27,200.00
25,161.00
9,429.00
Cost of Revenue
15,500.00
15,500.00
14,000.00
13,576.00
5,394.00
Gross Profit
15,300.00
15,300.00
13,200.00
11,585.00
4,035.00
Operating Expense
40,100.00
40,100.00
43,900.00
41,492.00
27,519.00
Operating Income
-24,800.00
-24,800.00
-30,700.00
-29,907.00
-23,484.00
Net Non Operating Interest Income Expense
300.00
300.00
-200.00
-332.00
5.00
Pretax Income
-24,500.00
-24,500.00
-30,900.00
-30,339.00
-23,462.00
Tax Provision
-2,800.00
-2,800.00
-4,000.00
-5,744.00
-3,146.00
Net Income Common Stockholders
-21,700.00
-21,700.00
-26,900.00
-24,595.00
-20,316.00
Diluted NI Available to Com Stockholders
-21,700.00
-21,700.00
-26,900.00
-24,595.00
-20,316.00
Basic EPS
-0.07
-0.07
-0.14
-0.14
-0.13
Diluted EPS
-0.07
-0.07
-0.14
-0.14
-0.13
Basic Average Shares
313,004.40
313,004.40
187,894.60
170,381.46
161,575.44
Diluted Average Shares
313,004.40
313,004.40
187,894.60
170,381.46
161,575.44
Total Operating Income as Reported
-24,800.00
-24,800.00
-30,700.00
-29,907.00
-23,484.00
Total Expenses
55,600.00
55,600.00
57,900.00
55,068.00
32,913.00
Net Income from Continuing & Discontinued Operation
-21,700.00
-21,700.00
-26,900.00
-24,595.00
-20,316.00
Normalized Income
-21,700.00
-21,700.00
-26,900.00
-24,513.93
-20,330.72
Interest Income
700.00
700.00
100.00
31.00
178.00
Interest Expense
400.00
400.00
300.00
363.00
173.00
Net Interest Income
300.00
300.00
-200.00
-332.00
5.00
EBIT
-24,100.00
-24,100.00
-30,600.00
-29,976.00
-23,289.00
EBITDA
-20,700.00
-20,700.00
-27,500.00
-27,414.00
-21,693.00
Reconciled Cost of Revenue
15,500.00
15,500.00
14,000.00
13,576.00
5,394.00
Reconciled Depreciation
3,400.00
3,400.00
3,100.00
2,562.00
1,596.00
Net Income from Continuing Operation Net Minority Interest
-21,700.00
-21,700.00
-26,900.00
-24,595.00
-20,316.00
Total Unusual Items Excluding Goodwill
--
--
--
-100.00
17.00
Total Unusual Items
--
--
--
-100.00
17.00
Normalized EBITDA
-20,700.00
-20,700.00
-27,500.00
-27,314.00
-21,710.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
--
-18.93
2.28
12/31/2020 - 12/9/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MHC.L MyHealthChecked PLC
15.25
0.00%
 
POLX.L Polarean Imaging plc
1.2000
+2.13%
 
IOB.DU Ion Beam Applications SA
12.98
-2.41%
 
NEOLA.ST Neola Medical AB (publ)
2.5400
-0.78%
 
2SE.F Sequana Medical NV
2.5400
-1.17%
 
8C4.F CYBERDYNE Inc.
1.0440
-0.19%
 
CYBQF CYBERDYNE Inc.
1.0350
0.00%
 
2SE.SG Sequana Medical NV
2.5400
-2.68%
 
ABT.VI Abbott Laboratories
110.40
+0.84%
 
EPIS-B.ST Episurf Medical AB (publ)
0.1318
-2.23%